Guj. Themis Biosyn - Quaterly Results

13 May 2023 Evaluate
Revenue showed a marginal decline at Rs. 281.73 millions. For the quarter ended March 2023, as compared to corresponding quarter of last year.A slim rise of 19.46% was recorded in the Net profit for the quarter ended March 2023 to Rs. 116.92  millions  From Rs. 97.87 millions.Operating Profit saw a handsome growth to 163.25 millions from 145.88 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 281.73 287.63 -2.05 1489.73 1148.54 29.71 1489.73 1148.54 29.71
Other Income 13.99 15.09 -7.29 60.24 40.50 48.74 60.24 40.50 48.74
PBIDT 163.25 145.88 11.91 802.42 620.96 29.22 802.42 620.96 29.22
Interest 0.25 1.79 -86.03 2.01 8.28 -75.72 2.01 8.28 -75.72
PBDT 163.00 144.09 13.12 800.41 612.68 30.64 800.41 612.68 30.64
Depreciation 7.69 5.44 41.36 25.76 22.33 15.36 25.76 22.33 15.36
PBT 155.31 138.65 12.02 774.65 590.35 31.22 774.65 590.35 31.22
TAX 38.39 40.78 -5.86 194.96 154.10 26.52 194.96 154.10 26.52
Deferred Tax 0.05 0.62 -91.94 2.55 0.72 254.17 2.55 0.72 254.17
PAT 116.92 97.87 19.46 579.69 436.25 32.88 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 57.95 50.72 14.25 53.86 54.07 -0.37 53.86 54.07 -0.37

Guj. Themis Biosyn Share Price

386.85 -3.30 (-0.85%)
16-Dec-2025 11:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.30
Dr. Reddys Lab 1275.95
Cipla 1505.00
Zydus Lifesciences 920.45
Lupin 2087.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×